Invest now
Marksans Pharma Balance Sheet Annual
BSE: 524404 | NSE: MARKSANS | ISIN: INE750C01026 | Sector: Biotechnology & Drugs330.45 -5.45 (-1.62%)Updated : 09 Sep 2026
Research on
| Fiscal Period | 2026 | 2025 | 2024 | 2023 |
|---|---|---|---|---|
| Period End Date | Mar 26 | Mar 25 | Mar 24 | Mar 23 |
| Total Liabilities Shareholders' Equity | 3,860.90 | 3,239.63 | 2,680.95 | 2,190.39 |
| Accumulated Depreciation Total | -463.53 | -351.10 | -300.10 | -236.29 |
| Cash Equivalents | 322.36 | 217.21 | 403.28 | 294.91 |
| Other Liabilities Total | 5.92 | 5.92 | 4.56 | 3.25 |
| Accrued Expenses | 21.60 | 19.46 | 14.18 | 10.44 |
| Common Stock Total | 45.32 | 45.32 | 45.32 | 45.32 |
| Other Equity Total | 337.41 | 167.19 | 89.85 | 89.85 |
| Other Current Assets Total | 2.00 | 1.81 | 59.94 | 36.19 |
| Prepaid Expenses | 36.89 | 30.26 | 25.13 | 19.80 |
| Total Assets | 3,860.90 | 3,239.63 | 2,680.95 | 2,190.39 |
| Current Portof LT Debt/ Capital Leases | 43.66 | 35.49 | 24.95 | 15.67 |
| Additional Paid- In Capital | 504.50 | 504.50 | 504.50 | 504.50 |
| Cash | 311.78 | 278.57 | - | 87.52 |
| Total Equity | 3,023.16 | 2,466.91 | 2,065.05 | 1,745.16 |
| Long Term Investments | 0.01 | 0.01 | 2.62 | 3.48 |
| Retained Earnings( Accumulated Deficit) | 2,135.94 | 1,749.91 | 1,425.39 | 1,105.50 |
| Total Common Shares Outstanding | 45.32 | 45.32 | 45.32 | 45.32 |
| Property/ Plant/ Equipment Total- Gross | 1,404.18 | 1,246.50 | 970.89 | 623.18 |
| Tangible Book Valueper Share Common Eq | 63.14 | 51.93 | 43.27 | 36.10 |
| Goodwill Net | 45.26 | 40.93 | 39.50 | 38.49 |
| Total Liabilities | 837.75 | 772.72 | 615.90 | 445.23 |
| Total Debt | 343.38 | 321.91 | 244.06 | 122.95 |
| Short Term Investments | 355.13 | 208.77 | 297.06 | 332.65 |
| Cashand Short Term Investments | 989.26 | 704.56 | 700.34 | 715.08 |
| Total Receivables Net | 704.90 | 609.26 | 459.14 | 419.48 |
| Notes Payable/ Short Term Debt | 29.59 | 23.09 | 29.09 | 41.59 |
| Deferred Income Tax | 5.09 | 3.66 | 10.62 | 15.39 |
| Accounts Receivable- Trade Net | 647.88 | 542.19 | 453.18 | 416.85 |
| Property/ Plant/ Equipment Total- Net | 940.66 | 895.41 | 681.09 | 386.89 |
| Minority Interest | 29.52 | 22.47 | 20.85 | 19.91 |
| Total Current Liabilities | 527.09 | 477.34 | 389.85 | 340.99 |
| Total Inventory | 989.68 | 858.23 | 617.94 | 484.74 |
| Accounts Payable | 336.91 | 305.70 | 268.28 | 230.60 |
| Other Currentliabilities Total | 95.33 | 93.60 | 53.35 | 42.69 |
| Total Long Term Debt | 270.13 | 263.33 | 190.02 | 65.69 |
| Intangibles Net | 116.78 | 72.73 | 64.76 | 70.80 |
| Other Long Term Assets Total | 16.83 | 3.56 | 29.38 | 14.57 |
| Note Receivable- Long Term | 18.63 | 22.87 | 1.11 | 0.87 |
| period Length | 0.00 | 0.00 | 0.00 | 0.00 |
| Total Current Assets | 2,722.74 | 2,204.12 | 1,862.49 | 1,675.30 |
| Capital Lease Obligations | 270.13 | 263.33 | 190.02 | 65.69 |
*All figures in crores except per share values
Marksans Pharma Quick Links
Marksans Pharma Dividend Marksans Pharma Bonus Marksans Pharma News Marksans Pharma AGM Marksans Pharma Rights Marksans Pharma Splits Marksans Pharma Board Meetings Marksans Pharma Key Metrics Marksans Pharma Shareholdings Marksans Pharma Profit Loss Marksans Pharma Cashflow Marksans Pharma Q1 Results Marksans Pharma Q2 Results Marksans Pharma Q3 Results Marksans Pharma Q4 Results
Equity Quick Links
Top GainersTop LosersIndian IndicesBSE Active StocksNSE Active Stocks
410.50+6.00(1.48%)
1,708.85+17.85(1.06%)
1,982.50+16.50(0.84%)
1,399.50-28.50 (-2.00%)
1,245.45-21.85 (-1.72%)
✕
Wait for it…
Oops! Looks like you have exceeded the limit to bookmark the image. Remove some to bookmark this image.